VanEck Biotech ETF
$187.37-0.57 %$BBH
About VanEck Biotech ETF (BBH)
VanEck Biotech ETF (BBH) is an exchange-traded fund established on December 20, 2011 and traded on the NASDAQ exchange. The fund manages approximately $0.39 billion in net assets, making it a significant ETF in its category.
With an expense ratio of 0.35%, VanEck Biotech ETF is considered a low-cost investment option for investors seeking exposure to this asset class.
The fund currently offers a dividend yield of 0.50%, providing income-seeking investors with supplemental distributions alongside potential capital appreciation.
What You Need to Know About BBH
- Inception Date: December 20, 2011 - providing 14 years of track record
- Assets Under Management: $0.39 billion in net assets
- Expense Ratio: 0.35% annually
- Dividend Yield: 0.50% annual yield
- Exchange: NASDAQ
- Type: Traditional ETF
Compare BBH with other investment options: ETF Screener | Stock Screener
Price History
▼-4.12%
Fund Details
Dividend Yield0.50%
Inception Date2011-12-20
Net Assets$391.3M
Net Expense Ratio0.00%